Zanamivir
Zanamivir is the first of two registered neuraminidase inhibitors for the treatment and prophylaxis of influenza. Zanamivir could inhibit SARS-CoV-2 3CLpro main protease.
| Trivial name | GG167 |
| Catalog Number | CSN12229 |
| Alternative Name(s) | GG167 |
| Research Area | Infection |
| Molecular Formula | C12H20N4O7 |
| CAS# | 139110-80-8 |
| Purity | ≥99% |
| SMILES | O=C(C1=C[C@H](NC(N)=N)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1)O |
| Size | 100mg |
| Supplier Page | https://www.csnpharm.com/products/zanamivir.html |